PFE

Bank of America lowers its price target on Pfizer to $26 from $27. The revision comes amid a reassessment of the product portfolio and pipeline. Analysts remain cautiously optimistic about long-term growth prospects.

AI-generated: summaries written by AI from the linked sources. How we use AI